GL1X · GenesisL1 explorer

Research workbench

Crystal structure of PFPK7 in complex with an ATP-site inhibitor

Analyse Crystal structure of PFPK7 in complex with an ATP-site inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2PMN
Type
protein
Length
340 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SER/THR protein kinase, putative
UniProt
Q7YTF7
Ligands
K51
Pockets
4 · best druggability 0.68

Structure

x-ray diffraction · 1 distinct chain · 32% helix, 22% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
XSER/THR protein kinase, putativeprotein34032% helix, 22% strandQ7YTF7

Ligands and binding sites

  • K51 · 4-(6-{[(1S)-1-(hydroxymethyl)-2-methylpropyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzonitrile · ligand · chains X

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14380.680.7948K51
21990.430.7324empty
3980.420.7815empty
4900.390.7619empty

Compared structures

  • 2PMN · Crystal structure of PfPK7 in complex with an ATP-site inhibitor · the same entry in another collection · chain X against X, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.